ArticleJornal vascular brasileiro2023

Successful use of rivaroxaban achieving therapeutic anti-factor xa levels in a morbidly obese patient with acute intermediate-high risk pulmonary embolism.

Kingsley Dah et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.